Company news – Page 3 – GeneTether, Inc.

GeneTether Therapeutics Inc. Files Final Prospectus for Initial Public Offering of Units

Vancouver, British Columbia – March 22, 2022

0

GeneTether Therapeutics Inc. Receives Notice of Allowance from USPTO

Vancouver, British Columbia – February 14, 2022

0

February 2, 2022

GeneTether Therapeutics Inc. Files Amended and Restated Preliminary Prospectus for Initial Public Offering of Units

Vancouver, British Columbia – February 2, 2022

0

November 17, 2021

GeneTether Therapeutics Inc. Files Preliminary Prospectus for Initial Public Offering of Units

Vancouver, British Columbia – November 8, 2021

0

October 20, 2021

GeneTether Announces Organizational Changes Designed to Support Continued Growth

Berkeley, CA, October 19, 2021

0

GeneTether Closes First and Second Financing Tranches

Berkeley, CA, March 23, 2021

0

February 18, 2021

GeneTether TNT™ Platform Granted Australian Patent

Berkeley, CA, February 18, 2021

0

February 18, 2021

GeneTether Announces Organizational Changes

Berkeley, CA, February 18, 2021

0

November 1, 2020

GeneTether Co-Founder, Geoffrey Sargent, Ph.D., Recognized as a UC Berkeley Extension 2020 Inspirational Instructor

Berkeley, CA, Nov. 1, 2020

0